48
Participants
Start Date
June 29, 2021
Primary Completion Date
January 15, 2024
Study Completion Date
January 31, 2026
FOLFOX regimen
"Leucovorin: 400 mg / m2 IV over 15 minutes on day 1 of each cycle. Fluorouracil (5-FU): 400mg / m2 IV bolus (15 min) followed by continuous IV infusion for 46 h of 2,400 mg / m2 on day 1 of each cycle.~Oxaliplatin 85 mg / m2 IV over 120 minutes on cycle day 1"
Anti-EGFR or Bevacizumab
"In case of RAS wt colorectal cancer administer anti-EGFR together with FOLFOX6m, and in case of mutated RAS colorectal cancer administer Bevacizumab together with FOLFOX6m.~Treatment administered following Summary of medicinal Product Characteristics (SmPC) approved indications."
LIVERPEARLS-Irinotecan
Chemoembolization of Irinotecan in 100 +/- 50 micron hydrogel microspheres. Irinotecan will be loaded at a dose of 100 mg. LIFEPEARLS® is a CE marked medical device consisting of microspheres for use in chemoembolization. This device allows the continuous release of irinotecan in liver tumors causing a specific necrosis. The penetration of irinotecan into the tumor tissue is deeper thanks to the microspheres, avoiding proximal occlusion of the vessels supplying the tumor.
H. Univ. Ramón y Cajal, Madrid
Hospital Universitari i Politècnic La Fe, Valencia
Hospital Clínic, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Parc Taulí, Sabadell
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Complejo Hospitalario de Navarra, Pamplona
Grupo Espanol Multidisciplinario del Cancer Digestivo
OTHER